Targeted therapy for cancer /

Saved in:
Bibliographic Details
Imprint:Oxford ; New York : Oxford University Press, 2003.
Description:xviii, 343 p., [4] p. of plates : ill. (some col.) ; 26 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/4865036
Hidden Bibliographic Details
Other authors / contributors:Syrigos, Konstantinos N.
Harrington, Kevin J., 1958-
ISBN:0198508964 (hbk. : alk. paper)
Notes:Includes bibliographical references and index.

MARC

LEADER 00000nam a22000007a 4500
001 4865036
003 ICU
005 20040330121700.0
008 030425s2003 enkaf b 001 0 eng
010 |a  2003535344 
015 |a GBA2-W6529 
016 7 |a 101167536  |2 DNLM 
020 |a 0198508964 (hbk. : alk. paper) 
040 |a NLM  |c NLM  |d UKM  |d DLC  |d OCoLC  |d OrLoB-B 
042 |a lccopycat 
050 0 0 |a RC271.I45  |b T37 2003 
060 0 0 |a 2003 C-022 
060 1 0 |a QZ 266  |b T185 2003 
082 0 4 |a 616.99406  |2 21 
245 0 0 |a Targeted therapy for cancer /  |c edited by Konstantinos N. Syrigos and Kevin J. Harrington. 
260 |a Oxford ;  |a New York :  |b Oxford University Press,  |c 2003. 
300 |a xviii, 343 p., [4] p. of plates :  |b ill. (some col.) ;  |c 26 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t The history of targeted therapy for cancer /  |r K. D. Bagshawe --  |g 2.  |t Preclinical models for the study of targeted therapy /  |r Gail Rowlinson-Busza --  |g 3.  |t Monoclonal antibody targeting therapy: an overview /  |r Roslyn J. Francis and Richard H. J. Begent --  |g 4.  |t Antibody-directed enzyme prodrug therapy (ADEPT) /  |r Konstantinos N. Syrigos and Kevin J. Harrington --  |g 5.  |t Monoclonal antibody targeted radionuclide therapy /  |r Surinder K. Batra, Apollina Goel, Gabriela Pavlinkova and David Colcher --  |g 6.  |t Combined external beam radiotherapy and radioimmunotherapy /  |r David Raben and Donald J. Buchsbaum --  |g 7.  |t Genetic immunotherapy for cancer /  |r Hardev S. Pandha --  |g 8.  |t Targeting of cancer gene therapy /  |r Kevin J. Harrington and Richard G. Vile --  |g 9.  |t Targeted genetic prodrug activation therapy /  |r Anne Rigg and Hardev S. Pandha --  |g 10.  |t Antisense therapy as a targeted modality /  |r Justin Waters and David Cunningham --  |g 11.  |t Dendritic cells - targeting the antitumor immune response /  |r Alan Melcher, Richard G. Vile, Andrew Bateman and Kevin J. Harrington --  |g 12.  |t Cell carriers for cancer gene therapy: bridging the gap between targeted vectors and systemic delivery? /  |r Rosa Maria Diaz, Heung Chong and Richard G. Vile --  |g 13.  |t Liposomal targeting of cytotoxic drugs /  |r Kevin J. Harrington and Konstantinos N. Syrigos --  |g 14.  |t Targeting blood vessels in vivo by using phage display libraries /  |r Claudia Vidal, Marina Cardo-Vila, Johanna Lahdenranta, Wadih Arap and Renata Pasqualini --  |g 15.  |t Photodynamic therapy /  |r Michael R. Hamblin --  |g 16.  |t Boron neutron capture therapy: a chemically targeted radiation modality /  |r Gerard M. Morris and Jeffrey A. Coderre --  |g 17.  |t Cancer immunotherapy directed at growth factor receptors: the ErbB/HER network as a prototype /  |r Michael Sela, Bilha Schecheter and Yosef Yarden --  |g 18.  |t Targeting the metastatic process /  |r Lloyd A. Culp, Wen-Chang Lin, Lanette R. Kleinman, Priit Kogerman, Raymond Judware, Carson J. Miller and Julianne L. Holleran. 
650 0 |a Cancer  |x Immunotherapy.  |0 http://id.loc.gov/authorities/subjects/sh87002642 
650 0 |a Cancer  |x Radioimmunotherapy.  |0 http://id.loc.gov/authorities/subjects/sh89007034 
650 0 |a Cancer  |x Gene therapy.  |0 http://id.loc.gov/authorities/subjects/sh92005201 
650 0 |a Drug targeting.  |0 http://id.loc.gov/authorities/subjects/sh88005350 
650 1 2 |a Neoplasms  |x therapy. 
650 2 2 |a Antibodies, Monoclonal. 
650 2 2 |a Gene Therapy. 
650 2 2 |a Immunotherapy. 
650 7 |a Cancer  |x Molecular aspects.  |2 fast  |0 http://id.worldcat.org/fast/fst00845397 
650 7 |a Cancer  |x Treatment.  |2 fast  |0 http://id.worldcat.org/fast/fst00845538 
650 7 |a Immunospecificity.  |2 fast  |0 http://id.worldcat.org/fast/fst00968032 
700 1 |a Syrigos, Konstantinos N.  |0 http://id.loc.gov/authorities/names/n00005972  |1 http://viaf.org/viaf/15025487 
700 1 |a Harrington, Kevin J.,  |d 1958-  |0 http://id.loc.gov/authorities/names/n2003127921  |1 http://viaf.org/viaf/66719518 
901 |a ToCBNA 
903 |a HeVa 
035 |a (OCoLC)50055138 
929 |a cat 
999 f f |i ef27be24-aaec-515d-bf0a-4f294d910872  |s e50c9179-3f3b-5e27-87ab-9328020b5923 
928 |t Library of Congress classification  |a RC271.I45 T37 2003  |l JCL  |c JCL-Sci  |i 4789370 
927 |t Library of Congress classification  |a RC271.I45 T37 2003  |l JCL  |c JCL-Sci  |e SPIT  |e CRERAR  |b 63625565  |i 7446518